ELISA PLA2G7 Antibody, FITC

Quantity :50µg Clone Number: Aliases:Platelet-activating factor acetylhydrolase precursor antibody; 1 alkyl 2 acetylglycerophosphocholine esterase antibody; 1-alkyl-2-acetylglycerophosphocholine esterase antibody; 2 acetyl 1 alkylglycerophosphocholine esterase antibody; 2-acetyl-1-alkylglycerophosphocholine esterase antibody; EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2 antibody; Group VIIA phospholipase A2 antibody; Group-VIIA phospholipase A2 antibody; gVIIA PLA2 antibody; gVIIA-PLA2 antibody; LDL associated phospholipase A2 antibody; LDL PLA(2) antibody; LDL PLA2 antibody; LDL-associated phospholipase A2 antibody; LDL-PLA(2) antibody; Lipoprotein associated phospholipase A2 antibody; LP PLA2 antibody; PAF 2 acylhydrolase antibody; PAF 2 acylhydrolase LDL associated phospholipase A2 antibody; PAF 2-acylhydrolase antibody; PAF acetylhydrolase antibody; PAFA_ antibody; PAFAD antibody; PAFAH antibody; Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma) antibody; PLA2G7 antibody; Platelet activating factor acetylhydrolase 2 antibody; Platelet activating factor acetylhydrolase antibody; Platelet-activating factor acetylhydrolase antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:Q13093 Immunogen:Recombinant Platelet-activating factor acetylhydrolase protein (49-441AA) Raised in:Rabbit Reactivity: Tested Applications: Background:ModµLates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids. Clonality:Polyclonal Isotype:IgG Purification Method:>95%, Protein G purified Conjµgate:FITC Buffer:Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:PLA2G7 Research Areas:CardiovascµLar; Immunology